Our findings are the first description of LMP2A alteration of LMP1 signaling by TRAF2 modulation in an animal model, and support similar findings in EBV-positive nasopharyngeal carcinoma and Burkitt's lymphoma cell lines [22], [41], [58]. The gene discussed is TRAF2; the disease is Burkitt lymphoma.